A phosphatase-recruiting bispecific antibody-aptamer chimera for enhanced suppression of tumor growth.
Sign Up to like & getrecommendations! Published in 2023 at "Chemical communications"
DOI: 10.1039/d3cc01137b
Abstract: The development of agents against abnormal activation of receptor tyrosine kinases (RTKs) for therapeutic interventions is in high demand. Using mesenchymal epithelial transition (Met) protein as a proof-of-concept RTK, here we developed a CD148-recruiting bispecific… read more here.
Keywords: aptamer chimera; recruiting bispecific; antibody aptamer; bispecific antibody ... See more keywords